<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(11)</volume><submitter>Kivrak M</submitter><pubmed_abstract>Breast cancer is the most common malignancy in women, with the Luminal A subtype generally associated with favorable survival. However, age and menopausal status may influence tumor biology and prognosis. To improve prediction beyond conventional models, we analyzed transcriptomic and clinical data from the METABRIC cohort. Patients with Luminal A breast cancer were stratified into premenopausal, postmenopausal-nongeriatric, and geriatric (≥70 years) groups. Differentially expressed genes (DEGs) were identified, and Boruta feature selection revealed 27 clinical and genomic variables. Random Forest, Logistic Regression, Multilayer Perceptron, and ensemble XGBoost models were trained with stratified 5-fold cross-validation, using SMOTE to correct class imbalance. Principal component analysis</pubmed_abstract><journal>Biology</journal><pagination>1539</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12650249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Integrative Machine Learning Model for Overall Survival Prediction in Breast Cancer Using Clinical and Transcriptomic Data.</pubmed_title><pmcid>PMC12650249</pmcid><pubmed_authors>Kesen O</pubmed_authors><pubmed_authors>Kivrak M</pubmed_authors><pubmed_authors>Nalkiran I</pubmed_authors><pubmed_authors>Sevim Nalkiran H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrative Machine Learning Model for Overall Survival Prediction in Breast Cancer Using Clinical and Transcriptomic Data.</name><description>Breast cancer is the most common malignancy in women, with the Luminal A subtype generally associated with favorable survival. However, age and menopausal status may influence tumor biology and prognosis. To improve prediction beyond conventional models, we analyzed transcriptomic and clinical data from the METABRIC cohort. Patients with Luminal A breast cancer were stratified into premenopausal, postmenopausal-nongeriatric, and geriatric (≥70 years) groups. Differentially expressed genes (DEGs) were identified, and Boruta feature selection revealed 27 clinical and genomic variables. Random Forest, Logistic Regression, Multilayer Perceptron, and ensemble XGBoost models were trained with stratified 5-fold cross-validation, using SMOTE to correct class imbalance. Principal component analysis</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-20T03:20:48.299Z</modification><creation>2026-05-20T03:09:57.557Z</creation></dates><accession>S-EPMC12650249</accession><cross_references><pubmed>41300329</pubmed><doi>10.3390/biology14111539</doi></cross_references></HashMap>